The FDA has recalled more than 233,000 bottles of antidepressant duloxetine, sold by Rising Pharmaceuticals, due to a potential cancer risk.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA recalls 233,000 bottles of antidepressant
